This study determined the efficacy of non-hormonal therapy with citalopram compared to fluoxetine, for the treatment of menopausal symptoms in Mexican women with vasomotor syndrome (VMS) and urogenital syndrome.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Change from baseline Menopause Rating Scale (MRS) total score at 3 months
Timeframe: 3 months
Change from baseline Menopause Rating Scale (MRS) total score at 6 months
Timeframe: 6 months
Change from baseline Menopause Rating Scale (MRS) somatic domain score at 3 months
Timeframe: 3 months
Change from baseline Menopause Rating Scale (MRS) somatic domain score at 6 months
Timeframe: 6 months
Change from baseline Menopause Rating Scale (MRS) urogenital domain score at 3 months
Timeframe: 3 months
Change from baseline Menopause Rating Scale (MRS) urogenital domain score at 6 months
Timeframe: 6 months
Change from baseline Menopause Rating Scale (MRS) psychological domain score at 3 months
Timeframe: 3 months
Change from baseline Menopause Rating Scale (MRS) psychological domain score at 6 months
Timeframe: 6 months
Change from baseline score in Item 1 of the Menopause Rating Scale (MRS) at 3 months
Timeframe: 3 months
Change from baseline score in Item 1 of the Menopause Rating Scale (MRS) at 6 months
Timeframe: 3 months